Le Lézard
Classified in: Health
Subject: SVY

The computer vision in healthcare market is projected to reach USD 1,457 million by 2023 from USD 210 million in 2018, at a CAGR of 47.2%


NEW YORK, Feb. 11, 2019 /PRNewswire/ -- Increasing demand for computer vision systems in the healthcare industry to drive the growth of the computer vision in healthcare market

Read the full report: https://www.reportlinker.com/p05732797

The computer vision in healthcare market is projected to reach USD 1,457 million by 2023 from USD 210 million in 2018, at a CAGR of 47.2% during the forecast period. The growth of this market is majorly driven by the increasing demand for computer vision systems in the healthcare industry, government initiatives to increase the adoption of AI-based technologies, big data in healthcare, and the use of computer vision in precision medicine. However, the reluctance of medical practitioners to adopt AI-based technologies and lack of awareness and technical knowledge are expected to restrain market growth to a certain extent during the forecast period.

Services segment to grow at the highest CAGR during the forecast period
Based on product & service, the computer vision in healthcare market is segmented into software, hardware, and services.The services segment is expected to grow at the highest CAGR during the forecast period.

The high growth of the services segment can be attributed to the recurring requirement of services such as training, software upgrades, and software maintenance post-installation.

The healthcare providers segment accounted for the largest share of the computer vision in healthcare market, by end user, in 2018
Based on end user, the computer vision in healthcare market is segmented into healthcare providers, diagnostic centers, and other end users.In 2018, the healthcare providers segment accounted for the largest share of the computer vision in healthcare market.

Factors such as the growing adoption of these solutions in hospitals and the increasing focus of companies on developing AI and computer vision tools to improve hospital operations are driving the growth of this end-user segment.

North America to dominate the computer vision in healthcare market during the forecast period
In 2018, North America accounted for the largest share of the computer vision in healthcare market.This market is also expected to grow at the highest CAGR during the forecast period.

The increasing number of imaging procedures for disease diagnosis is a major factor driving market growth.

The primary interviews conducted for this report can be categorized as follows:
? By Company Type: Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
? By Designation: C-level: 25%, D-level: 20%, and Others: 55%
? By Region: North America: 40%, Europe: 27%, Asia: 20%, and the RoW: 13%

List of Companies Profiled in the Report
? NVIDIA Corporation (US)
? Microsoft (US)
? Intel Corporation (US)
? Xilinx Inc. (US)
? IBM (US)
? Google (US)
? Basler AG (Germany)
? Arterys (US)
? AiCure (US)
? iCAD Inc. (US)

Research Coverage
This report provides a picture of the global computer vision in healthcare market.It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region.

Furthermore, the report also includes an in-depth competitive analysis of key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report
The report will help market leaders/new entrants by providing them the closest approximations of the revenue numbers for the overall computer vision in healthcare market and its subsegments.Also, this report will help stakeholders to better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies.

It will also enable stakeholders to understand the pulse of the market and provide them with information on key market drivers, restraints, challenges, and opportunities.

Read the full report: https://www.reportlinker.com/p05732797

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 06:50
Merck , known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA, Merck's anti-PD-1 therapy, in combination with platinum-containing chemotherapy as neoadjuvant treatment, then...

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...



News published on and distributed by: